Aarkstore Enterprise - Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts

Aarkstore announce a new report "Polycystic Ovarian Syndrome - Pipeline Assessment

and Market Forecasts to 2017" through its vast collection of market research report.

Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts to 2017 ; is a new report from industry analysis specialists. The report is an essential source of information and analysis on the global Polycystic Ovarian Syndrome (PCOS) market. The report identifies the key trends shaping and driving the global PCOS market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global PCOS sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

We estimate the Polycystic Ovarian Syndrome (PCOS) market to be worth $706m in 2009 and projects it to grow at a CAGR of 0.6% to reach $742m in 2017. The market is expected to decrease by 30.1% from $805m in 2011 to $563m in 2012. The decrease in the market will be due to the expiry of Letrozoles patent in the year 2011.

The market will gain pace from 2013 and will grow to $742m in 2017. The slow growth rate is largely because of the under diagnosis of this syndrome. However, the market is driven by an increasing prevalence rate, diagnosis rate and treatment seeking rate. The rise in the prescription population will contribute to the growth of the PCOS market. Due to the presence of a large number of generic products and a weak pipeline, this market will not grow at a significant rate.

Scope

- The report provides information on the key drivers and challenges of the Polycystic Ovarian Syndrome (PCOS) market. Its scope includes:

- Annualized global PCOS market revenues data from 2001 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as estrogen antagonists, female gamete inhibitor, insulin secretion inhibitor, HMG CoA inhibitor, Gastric and pancreatic lipase inhibitor and fats break down inhibitor.

- Analysis of the current and future competition in the global PCOS market. Key market players covered are Merck KGaA, Catalysis SL and Amylin Pharma.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the PCOS therapeutics market

For more information, please visit:

http://www.aarkstore.com/reports/Polycystic-Ovarian-Syndrome-Pipeline-Assessment-and-Market-Forecasts-to-2017-65062.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise - Polycystic Ovarian Syndrome - Pipeline Assessment and Market Forecasts

By: Pushpanjali

POST COMMENT

the actual notebook power adapter performance Follow guidelines and get glittering engagement rings of your ladylove's choice Journal of Personal Selling & Sales Management Aarkstore Enterprise - Autistic Disorder - Pipeline Assessment and Market Forecasts to 2017 Young Man Makes $ 32 Million In 6 years And Shares His Secrets To The World Aarkstore Enterprise Acute Myeloid Leukemia AML Pipeline Assessment and Market Forecasts Advertisements Aarkstore Enterprise - Atopic Dermatitis - Pipeline Assessment and Market Forecasts to 2017 Anti Aging Botox Treatment – Your Answer To Skin Aging Best 3 BHK Flats in Gurgaon with Top Class Amenities Reasons For Underarm Botox Injections Treatment What's Up With All These Women Getting Injections to Reduce Wrinkles? Don't They Know What That Is? The diamond solitaire engagement ring out of fashion